Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString Highlights Record Number of nCounter and GeoMx Research Studies at 2019 American Association of Cancer Research (AACR) Conference
Approximately 70 Abstracts Showcase NanoString’s Platforms, Including 13 Studies Using the GeoMx Digital Spatial Profiler SEATTLE , March 26, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic
View HTML
Toggle Summary NanoString Technologies Announces Closing of Public Offering of 5,175,000 Shares of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
SEATTLE , March 25, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 5,175,000 shares of its
View HTML
Toggle Summary NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock
SEATTLE , March 19, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 4,500,000 shares of its common stock at a price
View HTML
Toggle Summary NanoString Technologies Announces Commencement of Public Offering of Common Stock
SEATTLE , March 18, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an underwritten public offering of 4,500,000 shares of its common stock pursuant to its shelf
View HTML
Toggle Summary NanoString Technologies Releases Fourth Quarter and Full Year 2018 Operating Results and Provides 2019 Outlook
SEATTLE , March 07, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the fourth quarter and year ended December 31, 2018.
View HTML
Toggle Summary NanoString to Present at the 39th Annual Cowen Healthcare Conference
SEATTLE , March 04, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 39th Annual Cowen Healthcare
View HTML
Toggle Summary NanoString Showcases GeoMx and Hyb & Seq Platforms at 2019 Advances in Genome Biology and Technology (AGBT) Conference
Nine Studies of GeoMx DSP for High-Plex Spatial RNA Profiling and Three Studies of Hyb & Seq for Clinical Applications SEATTLE , Feb. 27, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic
View HTML
Toggle Summary NanoString to Host Inaugural Spatial Genomics Summit on Wednesday, February 27th at the 2019 Advances in Genome Biology and Technology (AGBT) Conference
Industry Experts to Provide Comprehensive Review of Emerging Spatial Techniques SEATTLE , Feb. 25, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company
View HTML
Toggle Summary NanoString to Release Fourth Quarter and Fiscal Year 2018 Financial Results and Host Conference Call on Thursday, March 7, 2019
SEATTLE , Feb. 21, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release fourth quarter and fiscal year 2018 financial results after the close
View HTML
Toggle Summary NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2018
— FY18 Product and Service Revenue of $83.5 million , Exceeding High-End of Guidance — — Generated Pre-Orders for More Than 30 GeoMx™ Digital Spatial Profilers — SEATTLE , Jan. 06, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for
View HTML